Search Results - "Buynak, E B"

Refine Results
  1. 1

    Human hepatitis B vaccine from recombinant yeast by McAleer, William J, Buynak, Eugene B, Maigetter, Robert Z, Wampler, D. Eugene, Miller, William J, Hilleman, Maurice R

    Published in Nature (London) (01-01-1984)
    “…The worldwide importance of human hepatitis B virus infection and the toll it takes in chronic liver disease, cirrhosis and hepatocarcinoma, make it imperative…”
    Get full text
    Journal Article
  2. 2

    Clinical Evaluation in Healthy Adults of a Hepatitis B Vaccine Made by Recombinant DNA by Scolnick, Edward M, McLean, Arlene A, West, David J, McAleer, William J, Miller, William J, Buynak, Eugene B

    “…A vaccine formulated from hepatitis B surface antigen (HBsAg) produced by a recombinant strain of the yeast Saccharomyces cerevisiae was administered to two…”
    Get full text
    Journal Article
  3. 3
  4. 4

    The preparation and safety of hepatitis B vaccine by Hilleman, M R, McAleer, W J, Buynak, E B, McLean, A A

    Published in The Journal of infection (01-07-1983)
    “…Preparation of hepatitis B vaccine in our laboratories consists of a series of steps that include initial concentration of surface antigen by ammonium sulphate…”
    Get more information
    Journal Article
  5. 5

    Cytogenetic evaluation of human endothelial cell cultures by Nichols, W W, Buynak, E B, Bradt, C, Hill, R, Aronson, M, Jarrell, B E, Mueller, S N, Levine, E M

    Published in Journal of cellular physiology (01-09-1987)
    “…Cytogenetic evaluation of serially subcultivated human endothelial cells revealed significant differences between cultures derived from fetal umbilical cords…”
    Get more information
    Journal Article
  6. 6
  7. 7
  8. 8

    Studies in chimpanzees of live, attenuated hepatitis A vaccine candidates by Provost, P J, Conti, P A, Giesa, P A, Banker, F S, Buynak, E B, McAleer, W J, Hilleman, M R

    “…Human hepatitis A virus was attenuated in virulence for chimpanzees by passage in FRhK6 and human diploid lung fibroblast cell cultures. A number of variants…”
    Get more information
    Journal Article
  9. 9
  10. 10
  11. 11

    Purified and inactivated human hepatitis B vaccine: progress report by Hilleman, M R, Buynak, E B, Roehm, R R, Tytell, A A, Bertland, A U, Lampson, G P

    “…Developments leading to the preparation and testing for safety and potency of a highly purified inactivated preparation of hepatitis B surface antigen are…”
    Get more information
    Journal Article
  12. 12
  13. 13
  14. 14

    Vaccine Against Human Hepatitis B by Buynak, Eugene B, Roehm, Robert R, Tytell, Alfred A, Bertland, Alexander U, Lampson, George P, Hilleman, Maurice R

    “…• A highly purified and inactivated vaccine was made of hepatitis B virus surface antigen. The vaccine was tested exhaustively for safety by ordinary…”
    Get full text
    Journal Article
  15. 15
  16. 16

    Development and chimpanzee testing of a vaccine against human hepatitis B by Buynak, E B, Roehm, R R, Tytell, A A, Bertland, 2nd, A U, Lampson, G P, Hilleman, M R

    “…Highly purified hepatitis B virus surface antigen (Australia antigen) purified by physical and chemical procedures from infected human plasma was used to…”
    Get more information
    Journal Article
  17. 17

    Vaccine against human hepatitis B virus prepared from antigen derived from human hepatoma cells in culture by McAleer, W J, Markus, H Z, Wampler, D E, Buynak, E B, Miller, W J, Weibel, R E, McLean, A A, Hilleman, M R

    “…Vaccine against human hepatitis B was prepared using antigen derived from hepatitis B carrier hepatoma cells grown in the interstices of a Diaflo hollow filter…”
    Get more information
    Journal Article
  18. 18
  19. 19

    Quality and safety of human hepatitis B vaccine by Hilleman, M R, McAleer, W J, Buynak, E B, McLean, A A

    “…Preparation of hepatitis B vaccine in our laboratories consists of a series of steps that include initial concentration of surface antigen by ammonium sulfate…”
    Get more information
    Journal Article
  20. 20

    Live attenuated varicella virus vaccine. Efficacy trial in healthy children by Weibel, R E, Neff, B J, Kuter, B J, Guess, H A, Rothenberger, C A, Fitzgerald, A J, Connor, K A, McLean, A A, Hilleman, M R, Buynak, E B

    Published in The New England journal of medicine (31-05-1984)
    “…We conducted a double-blind, placebo-controlled efficacy trial of the live attenuated Oka/Merck varicella vaccine among 956 children between the ages of 1 and…”
    Get more information
    Journal Article